Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Richard Ross

Concepts (50)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
3
2024
563
0.420
Why?
Receptor, EphB4
1
2024
33
0.210
Why?
Ephrin-B2
1
2024
45
0.210
Why?
Calcitonin Gene-Related Peptide
1
2024
39
0.200
Why?
Cancer Pain
1
2024
41
0.200
Why?
Spiral Cone-Beam Computed Tomography
1
2023
5
0.200
Why?
Bone Neoplasms
1
2024
272
0.170
Why?
Pancreatectomy
1
2024
289
0.170
Why?
Neoadjuvant Therapy
1
2024
475
0.160
Why?
Deoxycytidine
1
2022
219
0.160
Why?
Feasibility Studies
1
2024
1135
0.150
Why?
Graft vs Host Disease
1
2022
283
0.150
Why?
Combined Modality Therapy
1
2022
1271
0.140
Why?
Adenocarcinoma
1
2024
927
0.120
Why?
Hematopoietic Stem Cell Transplantation
1
2022
704
0.120
Why?
Palliative Care
1
2024
1032
0.110
Why?
Pancreatic Neoplasms
1
2024
944
0.110
Why?
Tumor Microenvironment
2
2024
747
0.070
Why?
Radiotherapy, Adjuvant
1
2024
222
0.050
Why?
Cone-Beam Computed Tomography
1
2023
32
0.050
Why?
Chemotherapy, Adjuvant
1
2024
429
0.050
Why?
Epithelial-Mesenchymal Transition
1
2024
219
0.050
Why?
Mice
3
2024
18297
0.040
Why?
Neoplasm Metastasis
1
2024
693
0.040
Why?
Pain Measurement
1
2024
573
0.040
Why?
Humans
6
2024
146342
0.040
Why?
Quality of Life
2
2024
3200
0.040
Why?
Pain Management
1
2024
421
0.040
Why?
Bone Marrow
1
2022
310
0.040
Why?
Transplant Recipients
1
2022
177
0.040
Why?
Survival Rate
1
2024
2092
0.040
Why?
Software
1
2023
676
0.030
Why?
CD8-Positive T-Lymphocytes
1
2024
931
0.030
Why?
CD4-Positive T-Lymphocytes
1
2024
1150
0.030
Why?
Animals
3
2024
38107
0.030
Why?
Cell Line, Tumor
1
2024
3545
0.030
Why?
Prognosis
1
2024
4351
0.030
Why?
Reproducibility of Results
1
2023
3416
0.030
Why?
Follow-Up Studies
1
2024
5439
0.030
Why?
Disease Progression
1
2022
2867
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
1998
0.030
Why?
Aged
2
2024
26432
0.030
Why?
Prospective Studies
1
2024
8123
0.020
Why?
Male
3
2024
73396
0.020
Why?
Middle Aged
2
2024
36619
0.020
Why?
Aged, 80 and over
1
2024
8391
0.020
Why?
Signal Transduction
1
2024
5246
0.020
Why?
Adult
2
2024
41087
0.020
Why?
Female
2
2024
79499
0.010
Why?
Retrospective Studies
1
2024
17438
0.010
Why?
Ross's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)